Jason M. Walsh
Gründer bei Provenance Biopharmaceuticals Corp.
Aktive Positionen von Jason M. Walsh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Provenance Biopharmaceuticals Corp.
 Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Gründer | 01.01.2008 | - |
| Corporate Officer/Principal | - | - | |
| Bioscience Network, Inc. | Präsident | 26.10.2010 | - |
Karriereverlauf von Jason M. Walsh
Ehemalige bekannte Positionen von Jason M. Walsh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | - | - |
Lexigen Pharmaceuticals Corp.
 Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Finanzdirektor/CFO | - | - |
Ausbildung von Jason M. Walsh
| University of Massachusetts | Undergraduate Degree |
| Babson College | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 6 |
| Deutschland | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| Director of Finance/CFO | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Provenance Biopharmaceuticals Corp.
Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Health Technology |
Lexigen Pharmaceuticals Corp.
Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Commercial Services |
| Bioscience Network, Inc. |
- Börse
- Insiders
- Jason M. Walsh
- Erfahrung
